Table of Contents
Metformin is a widely used oral medication primarily prescribed for the management of type 2 diabetes mellitus. Its effectiveness and safety profile have made it a cornerstone in diabetes treatment worldwide.
Introduction to Metformin
Developed in the 1950s, metformin belongs to the biguanide class of drugs. It is known for its ability to lower blood glucose levels without causing significant hypoglycemia, making it a preferred first-line therapy for type 2 diabetes.
Mechanism of Action
Metformin primarily exerts its glucose-lowering effects through the suppression of hepatic gluconeogenesis. It also enhances insulin sensitivity in peripheral tissues, such as skeletal muscle and adipose tissue.
Inhibition of Hepatic Gluconeogenesis
Metformin activates AMP-activated protein kinase (AMPK), a cellular energy sensor. Activation of AMPK inhibits key enzymes involved in gluconeogenesis, reducing the production of glucose by the liver.
Enhancement of Insulin Sensitivity
By improving insulin sensitivity, metformin facilitates increased glucose uptake in muscle and fat tissues. This leads to a reduction in circulating blood glucose levels.
Pharmacokinetics
Metformin is absorbed primarily in the small intestine and is not metabolized significantly in the body. It is excreted unchanged via the kidneys, emphasizing the importance of renal function in its clearance.
Absorption and Distribution
After oral administration, peak plasma concentrations are typically reached within 2-3 hours. It distributes mainly in the gastrointestinal tract, kidneys, and liver.
Elimination
Renal excretion is the primary route of elimination. Impaired kidney function can lead to accumulation and increased risk of lactic acidosis, a rare but serious side effect.
Adverse Effects and Precautions
Common side effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Lactic acidosis is a rare but potentially fatal complication, especially in patients with renal impairment.
Precautions
- Assess renal function before initiating therapy.
- Avoid use in patients with severe renal impairment.
- Discontinue before procedures involving iodinated contrast agents.
Conclusion
Metformin remains a cornerstone in the management of type 2 diabetes due to its effective glucose-lowering mechanism, favorable safety profile, and positive effects on cardiovascular health. Understanding its pharmacology helps optimize its use and manage potential risks.